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INTRODUCTION 
 Myopathies are disorders in which a primary functional or 
structural impairment of skeletal muscle exists.Muscle disorders are 
differentiated from disorders involving motor neurons,peripheral nerves 
or neuromuscular junction, by their characteristic clinical and laboratory 
features. Therefore, the approach to a patient with a suspected muscle 
disease is to determine the correct site of the lesion from history and 
physical examination. Once localized to the muscle, the next step is to 
identify whether the myopathy is due to a defect in the muscle channel, 
muscle structure, or a dysfunction in muscle metabolism. Subsequently 
the cause of the myopathy is to be determined.  
 In general, Muscle disorders are classified into hereditary and 
acquired disorders. Hereditary muscle disorders have classical age at 
onset, inheritance pattern, clinical profile, pattern of involvement and 
distinct laboratory features which helps in the diagnosis. This will help to 
decide on management and prognostication issues. It is also essential to 
identify treatable acquired muscular disorders and to differentiate them 
from hereditary muscle disorders. We undertook this study of hereditary 
muscle disorders to identify the clinical patterns and laboratory findings 
in these conditions and study the correlation between them, which will 
help in recognizing them early for adequate management with 
rehabilitation measures and for prognostication. 
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AIMS AND OBJECTIVES 
The aim of the study is, 
1. To study the demographic profile in Hereditary muscle disorders. 
2. To study the clinical spectrum of hereditary muscle disorders. 
3. To Assess the correlation between the clinical and investigational 
profile in Hereditary muscle disorders. 
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REVIEW  OF LITERATURE 
A CLINICAL APPROACH TO THE PATIENT WITH 
SUSPECTED MYOPATHY 
CLINICAL EVALUATION 
 The approach to a patient with suspected myopathy is by obtaining 
a thorough history for preliminary diagnosis and a detailed physical 
examination, including the pattern of muscle weakness, which provides 
further information in determining the correct diagnosis.1 The laboratory 
studies then, play a confirmatory diagnostic role. 
 Based on the  symptoms and signs,the clinical approach in a patient 
includes the following steps  
(1) Symptoms and Signs Associated With Myopathies 
1. Negative 
• Weakness 
• Fatigue 
• Exercise intolerance 
• Muscle atrophy 
2. Positive 
• Myalgias 
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• Cramps 
• Contractures 
• Myotonia 
• Myoglobinuria 
 Symptoms and signs of muscle disease are divided into negative 
complaints such as weakness, exercise intolerance, fatigue, and muscle 
atrophy, and positive complaints such as myalgias, cramps, contractures, 
myoglobinuria, myotonia and muscle stiffness.3  
 Weakness is the most common negative symptom reported by a 
patient with muscle disease.The proximal muscle weakness is the 
most common type of weakness in a myopathic disorder.Less 
commonly,patients with myopathies can complain of distal 
weakness . Some myopathies may also result in cranial muscle 
weakness,resulting in dysarthria,dysphagia, or ptosis. 
 Fatigue is a much less useful nonspecific negative symptom, and 
reflects a patient’s cardiopulmonary status, level of conditioning, 
overall health, sleeping habits, or emotional state. Abnormal 
fatigability after exercise can result from certain metabolic and 
mitochondrial myopathies. Myalgia, is another nonspecific 
(positive)symptom of some myopathies.Myalgias may be episodic 
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(metabolic myopathies) or nearly constant (inflammatory muscle 
disorders).  
 A specific type of muscle pain is the involuntary muscle cramp, 
lasting  from seconds to minutes and are usually localized to a 
particular muscle region.They are usually benign, occurring 
frequently in normal individuals,and are not a feature of a primary 
myopathy. Cramps are characterized by rapidly fir ing motor unit 
discharges,which can be demonstrated on needle EMG. Cramps 
can occur with dehydration,hyponatremia, azotemia, and 
myxedema and in disorders of the nerve or motor neuron 
(especially amyotrophic lateral sclerosis). Contractures differ from 
cramps in that they usually last longer and are electrically silent 
with needleEMG. 
 Myotonia is the phenomenon of impaired relaxation of muscle after 
forceful voluntary contraction , commonly involving the hands 
,eyelids and is due to repetitive depolarization of the muscle 
membrane.Patients may complain of muscle stiffness  resulting in 
difficulty releasing their handgrip after a handshake or opening 
their eyelids if they forcefully shut their eyes. Myotonia classically 
improves with repeated exercise but the patients with paramyotonia 
congenita demonstrate ‘‘paradoxical myotonia’’ in which 
symptoms are typically worsened by repeated muscle contractions. 
Exposure to cold results in worsening of both myotonia and 
paramyotonia. 
 Myoglobinuria is a relatively uncommon manifestation of muscle 
disease,is caused by the release of myoglobin from muscle during 
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periods of rapid muscle destruction (rhabdomyolysis) and can 
result in renal failure due to acute tubular necrosis..Recurrent 
myoglobinuria is usually due to an underlying metabolic 
myopathy,but isolated episodes occurring after unaccustomed 
exercise, are frequently idiopathic. 
(2)Temporal evolution 
 It is important to determine the onset, duration, and evolution of 
the patient’s symptoms and signs of muscle disease.Onset of  symptoms 
in Duchenne muscular dystrophy is usually by age 3, whereas most 
facioscapulohumeral and limb-girdle muscular dystrophies begin in 
adolescence or later. Dermatomyositis occurs in children and 
adults,polymyositis occurs rarely in children but at any decade in the 
adult years and inclus ion body myositis occurs most commonly in the 
elderly. 
 It is important to determine the duration and evolution of the 
disease. Muscle disorders with (1)constant weakness include muscular 
dystrophies, inflammatory myopathies and (2) episodic weakness with 
normal strength interictally inc lude periodic paralys is, metabolic 
myopathies. The episodic disorders have acute weakness that  returns to 
normal strength within hours or days. The disorders with constant 
weakness can be (1) acute or subacute progression as in some 
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inflammatory myopathies, (2) chronic slow progression over years as in 
most muscular dystrophies or (3) nonprogressive weakness with little 
change over decades as in congenital myopathies.  
(3)  Family history  
 Since many muscle disorders are inherited, obtaining a thorough 
family history is clearly of great importance in making a correct 
diagnosis. A detailed family tree is necessary for evidence of 
autosomal dominant, autosomal recessive, or X-linked patterns of 
transmission. Identifying a  hereditary pattern is also of importance 
in providing appropriate genetic counseling. 
(4) Precipitating factors that trigger episodic weakness or myotonia 
 A history of precipitating factors that trigger or exacerbate 
symptoms should be explored. 
• Illegal drug or prescription medication use  
• Exercise  induced Weakness, pain or myoglobinuria might suggest 
the possibility of a glycolytic pathway defect. 
• Fever with episodes of weakness would be supportive of a 
diagnosis of carnitine palmityl transferase deficiency.  
• Periodic paralys is is characteristically provoked by exercise or 
ingestion of a carbohydrate meal followed by a period of rest.  
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• cold exposure precipitating muscle stiffness occurs in Patients with 
paramyotonia congenita. 
(5) Associated systemic symptoms or signs 
 Involvement of organs or tissues other than muscle may also 
provide clues in making the appropriate diagnos is. 
• Cardiac disease may be associated with myotonic dystrophy, 
Duchenne or Becker muscular dystrophies,LGMD1B 
(laminopathy), LGMD2I(fukutin-related protein),LGMD2C–
2F(sarcoglycanopathies), LGMD2G (telethoninopathy),Emery-
Dreifuss muscular dystrophy, and Andersen syndrome. 
• Respiratory failure may be the presenting symptom of myotonic 
dystrophy,centronuclearmyopathy, nemaline myopathy, or acid 
maltase deficiency. 
•  Hepatomegaly may occur in myopathies with deficiencies in acid 
maltase, debranching enzyme and carnitine.  
• The presence of cataracts,frontal balding, and mental retardation 
strongly suggests the diagnosis of myotonic dystrophy.  
• Dysmorphic features may be associated with the congenital 
myopathies.  
• The presence of a rash is extremely helpful in confirming the 
diagnosis of dermatomyositis. 
 9 
• Contractures developing early in the course of the disease occurs in 
LGMD1B(laminopathy), Emery-Dreifuss dystrophy and Bethlem 
myopathy. 
• Evidence of diffuse systemic disease can indicate amyloidosis, 
sarcoidosis, endocrinopathy,collagen–vascular disease,infectious 
disease, or a mitochondrial disorder. 
(6) Distribution of weakness 
 To determine the distribution of weakness, muscle strength is 
assessed using the expanded Medical Research Council (MRC) of Great 
Britain grading scale of 0 to 5.2     
(7) Muscle atrophy 
• Atrophy of proximal limb muscles is common in most chronic 
myopathies.  
• Atrophy in specific groups that correspond to severe weakness in 
the muscles, provide additional diagnostic clues.  
a. Atrophy of the periscapularmuscles with winging of scapula 
occurs in facioscapulohumeral dystrophy.  
b. Scapular winging is also occurs in LGMD1B (laminopathy), 
LGMD2A (calpainopathy),and LGMD2C–2F 
(sarcoglycanopathies). 
c. In inclusion body myositis Selective atrophy of the 
quadriceps muscles and forearm flexor muscles occur.  
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d. Atrophy of the anterior or posterior lower extremity 
compartments occur in Distal myopathies. 
(8) Muscle hypertrophy 
a. Muscle  hypertrophy occurs in conditions such as 
myotonia congenita, amyloidosis, sarcoidosis,and 
hypothyroid myopathy.   
b. Calf muscles hypertrophy occurs in Duchenne and 
Becker dystrophy, LGMD2C–2F 
(sarcoglycanopathies)and LGMD2I (fukutin-related 
protein).  
c. In LGMD2G (telethoninopathy),50% of the patients will 
show calf hypertrophy and 50% will demonstrate calf 
atrophy.  
d. Focal muscle enlargement can also be due to a neoplastic 
or inflammatory process, ectopic ossification, tendon 
rupture, or partial denervation. 
 11 
PATTERN-RECOGNITION APPROACH TO 
MYOPATHIC DISORDERS 
 Myopathies usually occurs in any one of the following six patterns 
of weakness which aids in the diagnosis of specific muscle disorders.4 
 Pattern 1: Proximal Limb-Girdle Weakness 
• The most common pattern is symmetrical weakness 
involving predominantly the proximal muscles of the legs 
and arms(limb-girdle).The distal muscles,neck extensor and 
flexor muscles are usually involved, but to a much lesser 
extent.This pattern of weakness is seen in most hereditary 
and acquired myopathies and therefore is the least specific in 
arriving at a particular diagnos is. 
 Pattern 2: Distal Weakness 
• This pattern of weakness predominantly involves the distal 
muscles of the upper or lower extremities (anterior or 
posterior compartment muscle groups).Depending on the 
diagnosis and severity of disease, proximal muscles may also 
be affected. The involvement is usually symmetrical. 
(Nonaka, Miyoshi etc.) 
 Pattern 3: Proximal Arm/Distal Leg Weakness 
• This pattern of weakness affects the periscapular muscles of 
the proximal arm and the anterior compartment muscles of 
the distal lower extremity (scapuloperoneal).When the 
weakness is asymmetrical with associated facial weakness, it 
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is suggestive of a diagnosis of facioscapulohumeral 
dystrophy.  
• Other hereditary myopathies  associated with a 
scapuloperoneal distribution of weakness include 
scapuloperoneal dystrophy, Emery-Dreifuss 
dystrophy,LGMD1B, LGMD2A, LGMD2C–2F, congenital 
myopathies, and acid maltase deficiency. 
 Pattern 4: Distal Arm/Proximal Leg Weakness 
• This pattern involves the distal forearm muscles (wrist and 
finger flexors) and proximal leg weakness involving the 
knee extensors (quadriceps) and is often asymmetrical 
between the two sides. This pattern is pathognomonic for 
inclusion body myositis (IBM). 
 Pattern 5: Ptosis With or Without Ophthalmoplegia 
• Ptosis with ophthalmoplegia and dysphagia occurs in 
oculopharyngeal muscular dystrophy. Ptosis with 
ophthalmoplegia but without dysphagia occurs in 
mitochondrial myopathies.ptosis with facial weakness 
,without ophthalmoplegia occurs in myotonic dystrophy. 
 Pattern 6: Prominent Neck Extensor Weakness 
• This pattern is also called as‘‘dropped head syndrome’’ 
occurs in isolated neck extensor myopathy and other 
neuromuscular diseases like amyotrophic lateral sclerosis 
and myasthenia gravis. 
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LABORATORY APPROACH IN THE EVALUATION OF 
A SUSPECTED MYOPATHY 
1) Creatine Kinase 
• The most useful laboratory study in patients with a suspected 
myopathy is creatine kinase.5 The CK is elevated in most of the 
muscle diseases but may be normal 
• in slowly progressive muscle disorders. The degree of elevation 
gives clue to the diagnosis of specific  myopathies. 
• Marked elevation of  CK  occurs in Duchenne dystrophy(10-100 
times normal),LGMD1C(caveolinopathy), 
LGMD2A(calpainopathy), and LGMD2B (dysferlinopathy). 
• In myopathies with severe muscle wasting,steroid 
administration,collagen diseases,hyperthyroidism or alcoholism,the 
CK levels may be normal or low.  
• Other than in myopathies,CK may be seen slightly elevated in 
motor neuron disease, Guillain-Barre syndrome or chronic 
inflammatory demyelinating neuropathy, hypothyroidism, 
hypoparathyroidism, seizures,muscle trauma(falls, intramuscular or 
subcutaneous injections, EMG studies), viral illnesses or strenuous 
exercise. 
• Race and gender also affect serum CK levels (above the normal 
range in some African American individuals and in males).5  
 14 
• CK isoenzymes are nonspecific,CK-MB are elevated in both 
cardiac and muscle disorders.CK-MM fraction is increased in 
myopathies. 
• Other enzymes such as aldolase,aspartate 
aminotransferase(AST),alanine aminotransferase(ALT), and lactate 
dehydrogenase(LDH) may be slightly elevated in myopathies.  
2) Electrophysiological Studies 
• Electrophysiology (nerve conduction studies and EMG), is a part 
of the routine investigation in a patient with a suspected myopathy. 
These studies confirm the localization as muscle and not the 
Anterior horn cell, nerve or neuromuscular junction.  
• In patients with myopathy, the nerve conduction studies (both 
motor and sensory conduction studies) are  normal.  
• Needle EMG study shows myogenic pattern (short duration, small-
amplitude motor units with early recruitment, complete 
interference pattern) in muscle disorders.6  
3) The Muscle Biopsy 
• Muscle biopsy is an important step in establishing the diagnos is in 
patients with suspected myopathy.7 
• Open or closed(needle or punch) biopsy procedure is needed to 
obtain a muscle specimen. 
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• Selection of the appropriate muscle to biopsy is more 
important.Muscles that shows MRC grade 4 strength are biopsied 
and is avoided in severely involved muscles or in muscles recently 
subjected to needle  EMG study.  
• In the upper extremities,the muscle of choice is the biceps; in the 
lower extremities, the best choice is the vastus lateralis.  
• Sometimes an imaging like muscle ultrasound,computed 
tomography, or magnetic resonance imaging is used to guide 
selection of the suitable muscle for biopsy. 
• Light microscopy, electron microscopy,biochemical studies, and 
immune staining are used to analyse the specimens. 
• Myopathic features include internalised nuclei, small and large  
round fibers, split fibers, degenerating and regenerating f ibers. 
Chronic myopathies show increased connective tissue and fat. 
• The hematoxylin and eosin (H&E) and modified Gomori trichrome 
are useful for routine histology. The MGT stain is helpful in 
detecting ragged red fibers, which  suggests a mitochondrial 
disorder. 
• The myosin adenos ine tr iphosphatase stains (alkaline pH 9.4 and 
acidic pH 4.3 and 4.6)are used for identifying fiber types. Type 1 
fibers stain lightly at alkaline and darkly at acidic pH levels, 
whereas the Type 2 fibers stain darkly at alkaline and lightly at 
acidic pH levels. Normally, twice as many type 2 as type 1 fibers 
are identified. A nonspecific type 1 fiber predominance is common 
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in a number of myopathies. Oxidative enzyme stains (nicotinamide 
adenine dinucleotide[NADH] dehydrogenase, succinate 
dehydrogenase (SDH), cytochrome-c oxidase) are used to diagnose 
myofibrillar and mitochondrial abnormalities. Acid and alkaline 
phosphatase reactions for necrotic and regenerating f ibers, 
respectively.  
• Periodic acid-Schiff (PAS) stain, oil red O stain and a Congo red 
stain  are ued for diagnosing glycogen storage diseases, lipid 
storage diseases and amyloid deposition respectively. 
• Qualitative biochemical enzymes stains can be done for 
myophosphorylase(McArdle’s disease), phosphofructokinase (PFK 
deficiency), and myoadenylate deaminase (MAD deficiency).  
• immunohistochemical techniques are used to detect muscle 
proteins that are deficient in some muscular dystrophies(eg, 
dystrophin in Duchenne and Becker dystrophy) or to identify 
products that are increased in certain inflammatory myopathies (eg. 
membrane attack complex in dermatomyositis). 
• Electron microscopy is used to detect the ultrastructural 
components of muscle fibers and aids in the diagnosis of some 
congenital myopathies, mitochondrial disorders.  
• Western blot analysis from muscle tissue can be performed for 
certain muscle proteins (dystrophin assays in Duchenne or Becker 
dystrophy). 
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4) Molecular Genetic Studies 
• The specific molecular genetic defect is now known for a large 
number of hereditary myopathies, and mutations can be identified 
by peripheral blood DNA analys is. 
• Molecular genetic testing now eliminates the need for muscle 
biopsy in many myopathies. This  is also helpful for detecting 
carrier status and for prenatal diagnosis. 
5) Other blood tests that are helpful to rule out the acquired myopathies 
include  thyroid function tests, parathyroid hormone levels and human 
immunodefic iency virus (HIV). In patients with an inflammatory 
myopathy, serological tests for other autoimmune conditions like 
systemic lupus erythematosus, rheumatoid arthritis, and other 
immunological markers (eg, Jo-1 antibodies) may be useful. A urine 
analys is can be done to detect the presence of myoglobinuria, if the urine 
tests positive for blood and no red blood cells are found. 
6) Forearm exercise test 
 It is done in patients with a suspected metabolic myopathy. The 
test is done by asking the patient to do isometric contractions using a 
handgrip dynamometer for a period 1 minute. A resting blood sample for 
venous lactate and ammonia is obtained at baseline and subsequently at 1, 
2, 4, 6,and 10 minutes after the completion of exercise. Normally a 
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threefold rise in lactate level is obtained. The absence of elevation of 
serum lactate after exercise is seen in phosphofructokinase deficiency, 
myophosphorylase deficiency and reduced in phosphoglycerate mutase 
deficiency. Forearm testing is normal in all disorders of fat metabolism 
and also in some glycolytic disorders with fixed muscle weakness, such 
as acid maltase deficiency. 
 This pattern-recognition approach to myopathy is helpful in 
narrowing down the differential diagnosis and therefore minimizing the 
number of laboratory studies that must be ordered to confirm the 
diagnosis. Careful consideration of the distribution of muscle weakness 
and attention to these common patterns of involvement in the context of 
other aspects of the neurological examination and laboratory evaluation 
will usually lead to a timely and accurate diagnosis.  
Muscle disorders are broadly classified as,8 
1. Hereditary 
• Muscular dystrophies 
• Myotonias 
• Channelopathies 
• Congenital myopathies 
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• Metabolic myopathies 
• Mitochondrial myopathies 
2.Acquired 
• Inflammatory myopathies 
• Endocrine myopathies 
• Myopathies associated with 
• other systemic illness 
• Drug-induced myopathies 
• Toxic myopathies 
MUSCULAR DYSTROPHIES 
DUCHENNE MUSCULAR DYSTROPHY (DMD) 
 It is one of the most common and severe of the muscular 
dystrophies, affecting approximately one in 3,300 male live-births.9 It is 
transmitted as an X-linked recessive trait. DMD is caused by the mutation 
in DMD gene which encodes a 427 kd protein called dystrophin. 
dystrophin connects the cytoskeletal protein (actin) to extracellular 
connective tissue matrix through transmembrane proteins(dystroglycans 
and sarcoglycans) and thus provides structural support to the sarcolemma 
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during muscle stretch. So, the absence of dystrophin results in damage to 
the muscles. 
 The disease onset is in early childhood, usually before the age of  
4 years and always before the age of 10 years. Walking is delayed in 
about half of the patients and due to severe proximal limb weakness they 
develop waddling gait and compensatory lumbar lordosis. In rising from 
the floor, affected children "climb up" their legs to the erect position 
(Gower’s manoeuvre). Muscle enlargement, the pseudohypertrophy (calf)  
is often present from birth.Progression may vary, but by the age of 12 or 
13 years the ability to walk is lost.Patients can have low IQ, 
cardiomyopathy. Most patients die before the age of 20 due to pulmonary 
or cardiac failure. 
 Elevated serum enzymes, especially CPK(10-100 times normal) 
and LDH. electromyography showing myopathic pattern. Muscle biopsy 
shows increased variation of fibre size, presence of large ‘opaque' or 
‘hyaline’ fibres, local areas of degenerating and regenerating f ibres, 
increased number of internal nuclei and infiltration of fat and connective 
tissue. Positive family history is helpful. In doubtful cases the diagnosis 
can be confirmed by dystrophin immunoblotting. Carrier detection as 
well as prenatal diagnos is is now possible. 
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Treatment 
 No specific therapy is available, Prednisolone (0.75 mg/kg/day) is 
effective in increasing muscle strength, function and slowing of the rate 
of deterioration.10  Exercises are encouraged and continued as long as 
possible.  Corrective surgery is considered in slowly progressive cases.  
Novel treatments are myoblast transfer and direct gene replacement 
utilising modified viral vectors. Genetic counselling is offered to the 
affected family. 
BECKER MUSCULAR DYSTROPHY (BMD) 
 This is also transmitted as an X-linked trait, with an incidence of 
about 10 per cent of DMD. Both DMD and BMD are due to genetic 
defects at the same locus on the X-chromosome, Xp2.12  They are 
virtually identical to those of DMD but the onset is usually after the age 
of 5 years. Most patients are still able to walk beyond the age of 12 and 
often into adolescence and adult life; death usually occurs between the 
third and fifth decades, and almost never before the age of 20. Mental 
retardation is not as common as in DMD, and electrocardiogram 
abnormalities are unusual. As in DMD, hypertrophy of the calves is often 
pronounced from childhood, and serum CPK is markedly increased even 
before weakness becomes manifest. EMG and muscle biopsy findings are 
similar to those of DMD but abnormalities tend to be milder. Treatment is 
similar to that of DMD. 
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EMERY DREIFUSS DYSTROPHY 
 This is a childhood-onset disease with multiple contractures 
inherited in X-linked recessive manner, associated with cardiomyopathy. 
It affects predominantly the humeroperoneal muscles. It is slowly 
progressive. Sudden death due to abnormalities of the conducting system 
of the heart is not uncommon. Serum CPK is slightly increased. ECG 
shows varying degrees of atrioventr icular block. Cardiac pacemaker 
implantation may be needed. 
Limb-Girdle Muscular Dystrophies  
 There is a large group of patients with muscular dystrophy who do 
not fit into the Duchenne/Becker, facioscapulohumeral, or 
scapuloperoneal categories. Children of both sexes in this group lack the 
hypertrophy of calves and other muscles; adults with late-onset forms 
have either pelvic or shoulder girdle involvement or both, and their facial 
muscles are spared. The inheritance is variable but the autosomal 
recessive forms are the most common. Either the shoulder girdle or pelvic 
girdle muscles may be first affected. Weakness and atrophy may become 
evident during either late childhood or early adult life and spread from 
shoulders to hips or vice versa. 
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 The later the onset of these disorders, the more likely that the 
course will be benign. In these lesser-affected patients the EMG is 
myopathic, the CK values are only moderately elevated and may be 
normal. More severe cases can have greatly elevated CK levels. Cardiac 
involvement is infrequent, and mental function is normal but there are 
exceptions including in cases of laminin A/C mutations (type 1B), FKRP 
(fukutin-related protein mutation) mutations (type 2I), and in the 
sarcoglycanopathies. 
 The limb-girdle dystrophies are classified as LGMD1 for the 
autosomal dominant types and LGMD2 for the recessive types, and 
further subclassified based on the specific genotype.13 At least 11 forms 
of autosomal recessive (LGMD type 2) and 6 forms of autosomal 
dominant (LGMD type 1) limb-girdle dystrophies have been defined, 
with some specific clinical phenotype, most with an identifiable mutation 
and a protein that in most cases turns out to be a constituent of the muscle 
membrane.  
Facioscapulohumeral Muscular Dystrophy  
 This is a s lowly progressive dystrophy involving primarily the 
musculature of the face and shoulders, often with long periods of nearly 
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complete arrest. The pattern of inheritance is usually autosomal 
dominant.14 
 The age of onset is usually between 6 and 20 years, but cases 
beginning in early adult life are occasionally encountered. Weakness and 
atrophy of the involved muscles are the major physical findings; 
pseudohypertrophy occurs only rarely and is slight. As a rule, the first 
manifestations are diff iculty in raising the arms above the head and 
winging of the scapulae, although bifacial weakness may have initially 
attracted attention, even in early childhood.The lips have a peculiar 
looseness and tendency to protrude.  
 The lower parts of the trapezius muscles and the sternal parts of the 
pectorals are almost invariably affected. By contrast, the deltoids may 
seem to be unusually large and strong, an appearance that may be 
mistaken for pseudohypertrophy. The scapulae are winged and elevated 
("angel-wing" appearance), and the clavicles stand out. Usually the biceps 
waste less than the triceps, and the brachioradialis muscles even less, so 
that the upper arm may be thinner than the forearm ("Popeye" effect). 
Pelvic muscles are involved later and to a milder degree, giving r ise to a 
slight lordosis and pelvic instability. The pretibial muscles weaken, and 
foot-drop is added to the waddling gait. The Beevor s ign, an upward 
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movement of the umbilicus on flexing the neck as a result of weakness of 
the lower abdominal muscles, is common. 
 Initially, and even throughout the course, the muscular weakness 
may be asymmetrical (winging of only one scapula). Many of the patients 
with milder degrees of this form of dystrophy are unaware that they have 
the disease. At any point, the disease may become virtually arrested. 
Nevertheless, 15 to 20 percent of patients eventually require a wheelchair. 
Mental function is normal. Exudative retinal detachment (Coats disease) 
and other retinal abnormalities are an integral part of the disease. Serum 
CK values are normal or slightly elevated. 
Scapuloperoneal Muscular Dystrophy 
 Mutation in the FHL-1 gene on the X-chromosome results in a 
distinctive pattern of progressive muscular weakness and wasting that 
involved the muscles of the neck, shoulders, and upper arms, and of the 
anterior tibial and peroneal groups, causing severe foot-drop. The onset of 
symptoms is in early or middle adult life, with diff iculty in walking 
because of bilateral foot-drop; symptoms referable to scapulohumeral 
involvement came later. Progression was slow, and none of the patients 
became severely incapacitated. In addition to the nonspecific histologic 
features of muscular dystrophy, some fibers contained eosinophilic 
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hyaline inclusions and rimmed vacuoles. It is now clear that there is 
genetic heterogeneity in these cases. 
MYOTONIC DYSTROPHY 
 This is transmitted as an autosomal dominant disorder with varying 
degree of expression. It involves not only muscles but also other systems. 
An unstable mutant gene on the long arm of chromosome 19 (19q 13.3) 
with an increased number of trinucleotide CTG repeats is responsible and 
encodes a protein-myotonin protein kinase.15 
 The age of onset in usually between 20 and 50 years. The clinical 
features include muscle weakness, predominantly in distal groups, 
associated with wasting and myotonia. Multisystem involvement is 
manifested by cardiopathy (ECG abnormalities and congestive failure in 
late stages), cataract, mental retardation, hypogonadism and other 
endocrine dysfunctions, and frontal balding.16 Atrophy of the temporalis, 
masseter and facial muscles gives rise to a typical "hatchet-faced" 
appearance. The speech is often dysarthric along with swallowing 
difficulty due to palatal, pharyngeal and tongue muscle involvement. 
Some patients may have external ophthalmoplegia in the early stages. 
 By 5 years of age, myotonia can be demonstrated either by 
percussion over the tongue, thenar eminence and wrist extensor muscles 
or by delayed handgrip relaxation, though it may be generalised.Affection 
of intercostal muscles and diaphragm leads to alveolar hypoventilation 
and respiratory insufficiency. Malabsorption syndrome may occur due to 
involvement of gastrointestinal smooth muscles. 
 27 
 In severe cases there is a high incidence of cataracts, testicular 
atrophy, premature balding, cardiac conduction defects and diabetes 
mellitus. Mental retardation is common. Death occurs by the age of 50 
years. There is a tendency to anticipation in successive generations. 
Congenital myotonic dystrophy is seen in approximately 25% of infants 
of affected mothers. It is a more severe form of the disease characterised 
by weakness of facial and bulbar muscles with neonatal respiratory 
insufficiency and impaired intelligence. 
 The diagnosis of myotonic dystrophy is based on clinical features 
in most cases. Serum CPK level is usually normal or minimally elevated. 
EMG is pathognomonic, showing high-frequency waxing and waning 
discharges and a myopathic pattern. Muscle atrophy, especially of type I 
fibres, in more than 50% of cases with increased numbers of central 
nuclei, ring fibres and sarcolemmal masses can be seen on muscle biopsy. 
Treatment 
 Phenytoin (5 mg/kg/d) is the preferred agent for patients who need 
antimyotonia drugs. Quinine (300-600 mg bid or tid) and procainamide 
(beginning with low dose and increasing slowly up to 4-6 g/d) are 
avoided in the elderly as they may affect cardiac conduction. The 
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calcium-channel blocker nifedipine has been reported to be effective in 
resistant cases.  
MYOTONIA CONGENITA (THOMSEN'S DISEASE) 
• This autosomal dominant disease is characterised by myotonia 
which is more noticeable on starting activity, especially after 
prolonged rest. Interestingly, the myotonia is exacerbated by cold 
and can be "worked off" with continuing activity. There may be 
hypertrophy of muscles diffusely. Strength is generally well 
preserved.Specific decrease in chloride conductance causes 
increased membrane resistance. This is seen in electrophysiologic 
studies of intercostal muscle biopsies. 
• The autosomal recessive variety has more pronounced muscle 
hypertrophy than that of the dominant form, and there is usually 
weakness. 
• Serum CPK level is normal and EMG shows myotonic discharges. 
Biopsy of muscles reveals normal architecture. Mexiletine, 
quinine, procainamide and diphenylhydantoin are useful in control 
of symptoms. 
PROXIMAL MYOTONIC MYOPATHY (PROMM) 
i) autosomal dominant inheritance, ii) proximal muscle weakness, iii) 
cataract, iv) myotonia mainly of the hand and proximal muscle. 
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 The onset is usually between the ages of 20 and 40 years. It runs a 
slowly progressive course without signif icant atrophy. Non-specific 
myopathy is seen on muscle histology. 
PERIODIC PARALYSIS AND CHANNELOPATHIES 
 Periodic paralys is is now included as a disorder of ion channels, 
popularly called "the channelopathies". Four types of ion channels have 
been identif ied till date and all of them seem to have at least one 
clinically recognised disorder. 
• Sodium channel disorders-Hyperkalaemic periodic paralysis 
,Normokalaemic periodic paralysis, Paramyotonia congenita 
Myotonia f luctuans, Myotonia permanens ,Acetazolamide-
responsive myotonia. 
• Calcium channel disorders- Central core disease ,Malignant 
hyperthermia, Hypokalaemic periodic paralysis. 
• Chloride channel disorders- Myotonia congenital(Thomsen’s 
disease), Generalised myotonia(Becker). 
• Potassium channel disorders- Episodic ataxia-myotonia 
syndrome, Long Q-T syndrome. 
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Table – 1  
Important features of the periodic paralysis 
 Hypo-kalaemic  Normo-kalaemic Hyper-kalaemic 
• Channel defect DHP Ca+++  Na+  Na+ 
• Age of onset 2nd to 3rd decade 1st decade 1st decade 
• Precipitating factor    
Fasting - - + 
Carbohydrate load + - - 
Potassium load - ± ++ 
Cold + + ++ 
Emotional stress + ± ++ 
     
Pregnancy + -  ++ 
• Cranial muscle 
involvement 
+ ± - 
• Permanent myopathy + + + 
• Serum CPK during attack 
   
• Treatment  Large-dose 
KCl, with 
acet azola-mide in 
the intervening 
period 
Large doses 
of Na+ 
Large doses of 
glucose with 
insulin; large 
intervening 
carbohydrate diet 
• - Absent; + present; ± may be present; ++ significantly present; raised. 
MITOCHONDRIAL DISORDERS 
 A dozen mitochondrial DNA mutations have been associated with 
neuromuscular, psychiatric, ophthalmologic, endocrine and 
gastrointestinal disorders. Basically, mitochondrial myopathy is 
considered to be a disorder of muscles with abnormal structure, size, form 
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and number of mitochondria in the muscle. Ragged red fibres, containing 
peripheral and intermyofibrillar accumulations of abnormal mitochondria 
seen with the modified Gomori tr ichrome stain, are the morphological 
hallmark of these disorders. For a simplified understanding, 
mitochondrial disorders mainly constitute infantile lactic acidosis, 
progressive external ophthalmoplegia, the Kearns-Sayre syndrome, 
myopathies and encephalomyopathies. 
 The Kearns-Sayre syndrome (KSS) is characterised by progressive 
external ophthalmoplegia and pigmentary retinopathy with onset before 
the age of 20 years, with one or more of the following features: ataxia, 
increased cerebrospinal fluid protein concentration (> 1 g/L) and cardiac 
conduction defects. Other features may include diabetes, 
hypoparathyroidism, short stature and deafness. 
 MERRF syndrome: Myoclonic epilepsy, encephalo-myopathy and 
ragged red fibres constitute the MERRF syndrome. This disorder has a 
maternal pattern of inheritance and affects complex IV of the respiratory 
chain. 
 MELAS syndrome: Mitochondrial encephalomyopathy with lactic 
acidosis and stroke-like episodes constitute this syndrome. It has maternal 
inheritance and affects complex I. 
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 Treatment of these disorders is disappointing. Steroids and 
respirator chain co-factors such as ubiquinone, menadione and ascorbic 
acid have been tried with variable results. 
DISORDERS OF GLYCOGEN METABOLISM 
 Glycogen metabolism influenced by specific enzyme deficiencies 
gives rise to a number of glycogen storage diseases involving the skeletal 
muscles chiefly, with or without other tissues. They are transmitted as an 
autosomal recessive trait and muscle involvement is seen in types II, III, 
IV, V and VII. 
 Type II glycogen storage disease (acid maltase deficiency - AMD) 
is manifested either as generalised rapidly progressive and invariably 
fatal disease of infancy (Pompe’s disease) or as a more benign 
neuromuscular disorder in childhood or adult life. The defect can be 
documented in muscles or cultured skin fibroblasts or body f luids.
 Type III glycogen storage disease (debranching enzyme - amylo 
1,6, -glucosidase deficiency): Skeletal muscle and liver involvement are 
the important manifestations of the disease. Genetic heterogeneity is seen 
in a number of cases. During the first month of life the infant fails to 
thrive and shows hepatomegaly. Hypotonia and proximal muscle 
weakness are detected on examination. Easy fatiguability, exercise 
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intolerance, muscle cramps, ketosis and hypoglycaemia may be seen in 
some cases. Hepatomegaly may resolve spontaneously by adolescence 
with normal development despite persistent enzyme defect. 
 Type IV glycogen storage disease (branching enzyme amylo  
1,4-1,6 trans-glucosidase deficiency) is an autosomal recessive disorder. 
The clinical picture is characterised by progressive cirrhosis and chronic 
hepatocellular failure causing death in childhood. Muscle hypotonia and 
wasting are found in many cases. Small deposits of polysaccharide with a 
finely granular and f ilamentous structure are seen in electron microscopy 
of muscle biopsy. 
 Type V glycogen storage disease (myophosphorylase deficiency, 
McArdle’s disease) is an inherited autosomal recessive disorder but with 
a 3:1 predominance in affected males. Intolerance to strenuous exercise is 
the dominant clinical feature along with pain, stiffness and weakness of 
exercising muscles which is relieved by rest. The early childhood and 
adolescent varieties are characterised by increased fatiguability, while in 
the late-onset cases severe muscle cramps and myoglobinuria may occur. 
Progressive muscle weakness and wasting gradually dominate the clinical 
picture with increasing age while myoglobinuria diminishes in course of 
time. Serum lactate fails to rise after forearm ischaemic exercise. The 
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diagnosis is confirmed by demonstration of glycogen in muscle histology 
and deficiency of phosphorylase in muscles histochemically and 
biochemically. 
 Type VII glycogen storage disease (phosphofructokinase 
deficiency) is an autosomal recessive disorder affecting the rate limiting 
enzyme of glycolysis and results in complete block of the glycolytic 
pathway. The clinical picture is similar to that of myophosphorylase 
deficiency in many aspects; exercise intolerance, cramps, myoglobinuria 
and progressive weakness occur in a few patients. 
DISORDERS OF LIPID METABOLISM 
 Deficiences of carnitine and carnitine palmityl transferase give r ise 
to muscle disorders affecting lipid metabolism. 
Carnitine deficiency 
 The myopathic carnitine deficiency is an autosomal recessive 
disorder with a normal serum carnitine level while carnitine concentration 
in muscle is decreased due to a defect in the active transport mechanism. 
Weakness, especially of the proximal limb, trunk and neck muscles 
starting in childhood is the usual clinical picture. Rapid worsening with 
severe respiratory muscle weakness leading to ventilatory failure may 
occur. Serum CPK is raised and the EMG shows non-specific myopathic 
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features. Innumerable lipid droplets accumulate in type I fibres and 
appear as empty spaces reacting with stains for neutral fat. 
Administration of carnitine orally may result in some improvement while 
prednisolone may give dramatic response in some patients. 
Carnitine palmityltransferase (CPT) deficiency 
 The clinical picture of CPT deficiency is dominated by 
myoglobinuria after exercise, more so in cold weather, after fasting or 
ingestion of fatty foods; occasionally acute renal failure ensues. 
 Transmitted as an autosomal recessive trait the patients are normal 
on clinical examination except during episodes of myoglobinuria.During 
an attack, muscle cramps, weakness and dark urine are presenting 
features which develop about 1-2 hours after exercise and last for 1 or 2 
days. Muscle enzymes are raised during an attack. There is normal rise of 
lactate in ischaemic forearm exercise test. Virtually no ketone body 
formation takes place on fasting. Lipid droplets are found in type I 
muscle fibres and deficiency of CPT is observed in muscle as also in 
liver, leucocytes, platelets and in cultured skin fibroblasts.  
Myoadenylate deaminase deficiency 
 It is an inherited disorder with males and females being equally 
affected. Fatigue, weakness, muscle cramps and soreness are experienced 
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following exertion. Though weakness is more pronounced in limb 
muscles, muscles of the trunk and chest may show variable involvement; 
characteristically the face and eye muscles are spared. In 50% of cases 
mild muscle weakness, atrophy, and tenderness on palpation may be 
found. Myoglobinuria has never been documented and fixed weakness 
has been noted in very few patients. Serum CPK is mildly raised and 
complex polyphasic units, positive sharp waves and low-amplitude action 
potentials are found on EMG. The lactate-ammonia exercise ratio is 
below 4% in affected individuals 
The Distal Muscular Dystrophies : 
 Included in this group are several slowly progressive distal 
myopathies with onset principally in adult life. Weakness and wasting of 
the muscles of the hands, forearms, and lower legs, especially the 
extensors, are the main c linical features. Several types of distal 
dystrophies are inherited as autosomal dominant traits which includes 
Welander distal dystrophy, Tibial muscular dystrophy, Scapuloperoneal 
dystrophy, Desmin myopathy ,Gower-Laing, Markesbury-Griggs. The 
autosomal recessive types include Miyoshi myopathy, Nonaka myopathy 
with rimmed vacuoles (familial IBM).1 
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MATERIAL AND METHODS 
Study Centre: 
• Institute of Neurology,Madras Medical College,Chennai 
Study design: 
• Cross sectional study 
Study period:  
• July 2012 to February 2013(8 months) 
Study Sample:  
• 44 patients (Males-32,Females-12)  
Inclusion criteria:  
• Patients with clinical features suggestive of Hereditary muscle 
disorders 
Exclusion criteria: 
The following patients are excluded from the study, 
• Patients with clinical features,electrodiagnostic tests (NCV/EMG) 
suggestive of neuropathies or neuromuscular junction disorders. 
• Patients with features suggestive of drug-induced myopathies. 
• Patients with features suggestive of toxic myopathies. 
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• Patients with features suggestive of Endocrine myopathies. 
• Patients with features suggestive of myositis 
(infective/inflammatory). 
• Patients with features of myopathy associated with other systemic 
illness. 
Clinical Evaluation: 
Clinical evaluation of all patients were done with, 
 Detailed history taking 
  Clinical examination  
i. General Examination with details about the presence of  
contractures,skeletal deformities,etc.  
ii. CNS Examination which included higher mental 
functions,cranial nerves, spinomotor 
system,reflexes,incoordination,sensory 
system,gait,cerebellar and extrapyramidal system 
examinations. 
iii. Muscle testing which included examination of muscle 
bulk,tone,power,reflexes,muscle tenderness, identifying 
specific pattern of muscle involvement and  other 
characteristic signs (eg. polyhill sign in FSHD). 
Investigations: 
 All the patients were subjected to routine blood investigations like 
complete blood count,blood sugar,renal function test,liver function 
 39 
test,routine urine analysis,thyroid function test,ECG/ECHO 
study,ophthalmologic evaluation. 
 Other specific investigations included, 
1)Serum CPK measurement:   
Test Procedure 
• Blood is drawn from a vein, usually from the arm. The 
venipuncture area is cleaned with  antiseptics. A tourniquet is 
placed around the upper arm to make the vein prominent. The 
needle is inserted into the vein, and the blood is allowed to collect 
in a blood collection tube. 
• The blood samples were centrifuged at 3000 RPM for ten minutes 
immediately after collection, and the serum was removed for 
analys is of CPK.  
• Total enzymatic activity was determined by spectrophotometry and 
kinetic method.The results are expressed in IU/L. 
2) Nerve conduction study (NCS): 
 Nerve conduction studies were done to evaluate the functioning of 
motor and sensory nerves. 
• The muscle electrical signal was recorded and the time from 
electrical stimulus to muscle contraction (latency),NCV,amplitude 
determined for both motor and sensory nerves. 
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3) Electromyography(EMG): 
 The EMG evaluation to determine the electrical function of 
individual muscle motor unit potentials at rest and during muscle 
contraction was done for all patients. 
Technique:  
• It is performed by inserting a recording needle electrode into the 
belly of a muscle. The needle tip is the recording electrode and the 
needle shaft is the reference electrode in a concentric needle.  
• Electrical activity from muscle fibers is recorded and amplif ied to 
appear on an oscilloscope as a tracing of voltages versus time with 
accompanying sound. 
• spontaneous activity, Motor unit action 
potentials(MUAPS),Interference pattern  were observed and 
interpreted as normal, myopathic or neurogenic patterns. 
• Interpretation: 
 Normal-no spontaneous activity, MUAPs with 3-4 
phases,amplitude of 0.5 to 2 mV, duration of 5-15ms and 
a normal interference pattern. 
 Neurogenic:spontaneous activity-present(positive sharp 
waves, fibrillationpotentials, fasciculations, MUAPs-
large amplitude, polyphasic, longer duration, interference 
pattern-incomplete. 
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 Myopathic- no spontaneous activity(except in myotonic 
dystrophy, where myotonic discharges are seen), 
MUAPs-normal to low amplitude, polyphasic,shorter 
duration, interference pattern-complete with early 
recruitment. 
4)Muscle Biopsy: 
• Technique: open biopsy procedure was used to obtain muscle 
specimen in all patients.Under local anesthesia ,a linear piece of 
muscle tissue of 1.5×0.5 cms size obtained. 
• Moderately affected muscles were selected for biopsy.In most 
of the occasion, Vastus lateralis was sampled and in some 
patients Tibialis anterior was biopsied.  
• Precautions  like avoiding  severely affected muscles,muscles 
tested by EMG etc. were followed 
• Muscle sample was preserved in saline moistened gauze for 
transportation to the lab. 
• One portion the specimen was flash freezed in isopentane and 
the cryosectioned specimen used for routine staining 
(HE/MGT),Enzyme staining(SDH/ATPase). 
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• 10% formalin f ixed paraffin sections were used for routine 
staining(HE/MAT/PTAH). 
Data Analysis: 
 All the data were tabulated in Microsoft XL sheet,followed by 
analys is using SPSS software(version 20.0). 
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RESULTS 
 A total of 44 patients were included in our study, out of which 
32(72.7%) were males and 12(27.3%) were females. 
Table -  2   
SEX DISTRIBUTION  
 
Frequency 
(n) % 
Male 32 73 
Female 12 27 
Total 44 100 



 44 
Table - 3  
DISTRIBUTION OF VARIOUS HEREDITARY  
MUSCLE DISORDERS 
DIAGNOS IS OF 
HEREDITARY 
MUSCLE DISORDERS 
FREQUENCY (n) PERCENT(%) 
DMD  2 4.55 
BMD  5 11.36 
FSHD  5 11.36 
LGMD  25 56.81 
MYOTONIC 
DYSTROPHY  
3 6.82 
DISTAL MYOPATHY 
 
2 4.55 
CONGENITAL 
MYOPATHY  
2 4.55 
Total 44 100 
 
 Among the total of 44 patients,25 were LGMD which accounts 
57% of patients.5 patients(11.4%) each in BMD and FSHD were 
observed.3 patients (6.8%) had myotonic dystrophy.2(4.5%) patients each 
in DMD,Congenital myopathy and diatal myopathy group were noted in 
our study. 

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Table  - 4  
SEX DISTRIBUTION IN VARIOUS HEREDITARY  
MUSCLE DISORDERS 
SEX DIAGNOS IS OF 
MUSCLE 
DISORDERS Male % Female % 
Total 
DMD (n = 2) 2 100 0 0 2 
BMD (n = 5) 5 100 0 0 5 
FSHD (n = 5) 4 80 1 20 5 
LGMD (n = 25) 16 64 9 36 25 
MYOTONIC 
DYSTROPHY (n = 3) 3 100 0 0 3 
DISTAL MYOPATHY 
(n = 2) 0 0 2 100 2 
CONGENITAL 
MYOPATHY (n = 2) 2 100 0 0 2 
p<0.091 

 Among 25 LGMD patients,16 (64%)were males and 9(36%) are 
females. Out of 5 patients with BMD, all 5(100%) were males.  Among 5 
FSHD, 4(80%) were males and 1(20%) was female.  3 patients had 
Myotonic dystrophy.  All 3(100%) were males.  Total of 2 had Distal 
Myopathy and all 2(100%) were females.  2 had Congenital Myopathy 
and all 2(100%) were males.  All 2(100%) patients with  DMD were 
males. 
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Figure - 1 
Biceps hump in a patient with LGMD  
 47 
Table - 5 
AGE DISTRIBUTION OF PATIENTS WITH HEREDITARY 
MUSCLE DISORDERS  
Age Groups (Yrs) DIAGNOS IS OF 
MUSCLE 
DISORDERS 1 – 10 11 – 20  21 – 30 31 – 40  41 – 50 
Total 
DMD (n = 2) 2 0 0 0 0 2 
BMD (n = 5) 3 1 0 1 0 5 
FSHD (n = 5) 1 2 0 1 1 5 
LGMD (n = 25) 3 11 6 4 1 25 
MYOTONIC 
DYSTROPHY (n = 3) 0 2 0 1 0 3 
DISTAL 
MYOPATHY 
(n = 2) 
0 0 2 0 0 2 
CONGENITAL 
MYOPATHY (n = 2) 0 2 0 0 0 2 
Total 9 18 8 7 2 44 
p<0.083 

  Among 25 patients with LGMD, 11(44%) belong to the age group 
of 11-20yrs, 6(24%) to 21-30yrs, 4(16%) to 31-40yrs, 3(12%) to 1-10yrs 
and 1(4%) to 41-50.  Out of 5 affected with FSHD, 2(40%) belong to the 
age group of 11-20yrs, 1(20%) to 1-10yrs, 1(20%) to 31-40yrs, 1(20%) to  
41-50yrs.  In a total of BMD patients, 3(40%) belong to age group of  
1-10yrs , 1(20%) in the age group of  11-20yrs and 1(20%) in the age 
group of 31-40 yrs.  out of 3with Myotonic dystrophy 2(66.67%) belong 
to age group of 11-20yrs and 1(33.33%) to 31-40yrs.  All 2 (100%) with 
Distal Myopathy belong to the age group of 21-30yrs.  All 2(100%) with 
Congenital myopathy belong to the age group of 11-20yrss.  All 2(100%) 
of DMD patients belong to age group of 1-10yrs.  The mean age of the 
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patients with muscle disorders was 24.38 yrs with Standard deviation 
(SD) 11.82 yrs. 
 
 
 
 
 
 
 
 
 
Table – 6  
DISTRIBUTION OF AGE AT ONSET AMONG  HEREDITARY 
MUSCLE DISORDERS 
Grouping of Age at onset of Disease DIAGNOS IS OF 
MUSCLE 
DISORDERS 1 – 10 11 – 20  21 – 30 31 – 40  41 – 50 
Total 
DMD (n = 2) 2 0 0 0 0 2 
BMD (n = 5) 3 1 1 0 0 5 
FSHD (n = 5) 1 2 0 1 1 5 
LGMD (n = 25) 3 11 6 4 1 25 
MYOTONIC 
DYSTROPHY (n = 3) 0 2 0 1 0 3 
DISTAL 
MYOPATHY 
(n = 2) 
0 0 2 0 0 2 
CONGENITAL 
MYOPATHY (n = 2) 0 2 0 0 0 2 
Total 9 18 9 6 2 44 
p 
<0.083 
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In a total of 25 patients with LGMD 11(44%) had disease onset 
between 11-20yrs, 6(24%) in 21-30yrs, 4(16%) in  31-40yrs, 3(12%) in 1-
10yrs and 1(4%) in 41-50yrs. Out of 5 affected with FSHD, 2(40%) had 
disease onset between  11-20yrs, 1(20%) in 1-10yrs,1(20%) in 31-40yrs 
and 1(20%) in 41-50yrs. Out of 5 patients with BMD, 3(40%) had disease 
onset in the age group of 1-10yrs , 1(20%) in 11-20yrs and 1(20%) in 21-
30 yrs.Out of 3 with Myotonic dystrophy,2(66.67%) had disease onset in 
the age group of 11-20yrs and 1(33.33%) in 31-40yrs.All 2 
(100%)patients with Distal Myopathy had disease at onset in the age 
group of 21-30yrs. All 2 (100%) with Congenital myopathy had disease 
at onset in the age  group of 11-20yrs. All 2(100%) patients with DMD 
had disease of onset in the age group of 1-10yrs.  The mean age of onset 
of the disease in patients with muscle disorders was 19.31 yrs with 
Standard deviation (SD) 11.08 yrs.  
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Table – 7  
DISTRIBUTION OF  PATIENTS WITH HEREDITARY MUSCLE 
DISORDERS AND DURATION OF THE DISEASE 
Duration of disease (Yrs)  Total 
 
DIAGNOS IS OF 
MUSCLE 
DISORDERS 1 – 5 6 – 10  11 – 15 16 – 20   
DMD (n = 2) 0 2 0 0 2 
BMD (n = 5) 3 1 1 0 5 
FSHD (n = 5) 2 1 2 0 5 
LGMD (n = 25) 16 8 1 0 25 
MYOTONIC 
DYSTROPHY (n = 3) 2 1 0 0 3 
DISTAL MYOPATHY 
(n = 2) 2 0 0 0 2 
CONGENITAL 
MYOPATHY (n = 2) 2 0 0 0 2 
Total 27 13 4 0 44 
p<0.574 
 
 Among  25 patients with LGMD, 16(64%)had a duration of 1-5yrs, 
8(32%) of 6-10yrs, 1(4%) of 11-15yrs. Out of 5 affected with FSHD, 
2(40%) were suffering for a period of 1-5yrs, 1(20%) for 6-10yrs and 
2(40%) for 11-15yrs. Among 5 patients with BMD, 3(40%) were 
suffering for a period of  1-5yrs , 1(20%) for 6-10yrs and 1(20%) for 11-
15yrs. Out of 3 patients with Myotonic dystrophy, 2(66.67%) had a 
duration of 1-5yrs and 1(33.33%) had duration of 6-10yrs. All 2(100%) 
patients with Distal myopathy were suffering for a period of 1-5yrs. All 
2(100%) affected with Congenital myopathy were suffering for a period 
of 1-5yrs. The 2(100%) DMD affected person had been suffering from 
the disease for 6-10yrs.  The mean duration of the disease in patients with 
muscle disorders was 5.3 yrs with Standard deviation (SD) 3.76 yrs. 
 51 
Table – 8 
INHERITANCE PATTERN IN VARIOUS HEREDITARY 
MUSCLE DISORDERS
FAMILY HISTORY 
 
DIAGNOS IS OF 
MUSCLE 
DISORDERS Autosomal  
Recessive 
Autosomal 
Dominant 
X-linked 
recessive 
Not 
clear 
 
Total 
DMD (n = 2) 0 0 2 0 2 
BMD (n = 5) 0 0 4 1 5 
FSHD (n = 5) 0 0 0 5 5 
LGMD (n = 25) 7 0 0 18 25 
MYOTONIC 
DYSTROPHY  
(n = 3) 
0 2 0 1 3 
DISTAL 
MYOPATHY 
(n = 2) 
0 1 0 1 2 
CONGENITAL 
MYOPATHY (n = 
2) 
1 1 0 0 2 
Total 8 4 6 26 44 
p<0.001 
 
 Among 25 patients with LGMD, 18(72%) had no or unclear family 
history and 7(28%) had autosomal recessive inheritance. None of the 
5(100%) patients with FSHD, had family history.  Among the 5 with 
BMD, 4(80%) have XR pattern of inheritance and 1(20%) had no family 
history. Out of 3 with Myotonic dystrophy, 2(66.7%) had autosomal 
dominant type of inheritance and 1(33.33%) had no family history. 
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Among 2 with Distal myopathy, 1(50%) had autosominal dominant type 
of inheritance and 1(50%) had no family history. Out of 2 with congenital 
myopathy 1(50%) had autosomal recessive type of inheritance and 
1(50%) had autosomal dominant type of inheritance. All 2(100%) with 
DMD had XR type of inheritance.  The distribution of the subjects with 
muscle disorders and type of their inheritance was found to be 
statistically signif icant (p<0.001). 
Table  - 9 
DISTRIBUTION OF THE SUBJECTS WITH DIAGNOSIS OF 
HEREDITARY MUSCLE DISORDERS AND SYMMETRICITY 
OF WEAKNESS 
WEAKNESS DIAGNOS IS OF 
MUSCLE 
DISORDERS Symmetrical(% ) Asymmetrical(% ) 
Total 
DMD (n = 2) 2 0 2 
BMD (n = 5) 5 0 5 
FSHD (n = 5) 2 3 5 
LGMD (n = 25) 24 1 25 
MYOTONIC 
DYSTROPHY (n = 3) 3 0 3 
DISTAL 
MYOPATHY 
(n = 2) 
2 0 2 
CONGENITAL 
MYOPATHY (n = 2) 2 0 2 
Total 40 4 44 
p<0.007 
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In a total of 25 patients with LGMD, 24(96%) had symmetrical 
weakness and 1(4%) had asymmetrical weakness.  Out of 5 patients with 
FSHD, 2(40%) had symmetrical weakness and 3(60%) had asymmetrical 
weakness. All 5 patients with BMD had symmetrical weakness. All 
3(100%) patients with Myotonic dystrophy had symmetrical weakness.  
All 2(100%) patients with DMD had symmetrical weakness.  All 
2(100%) patients with Distal Myopathy had symmetrical weakness.  All 
2(100%) suffering from Congenital myopathy had symmetrical weakness.  
Distribution of subjects with diagnos is and pattern of weakness was 
found to be statistically significant(p<0.007). 
Table  - 10 
DISTRIBUTION OF THE WEAKNESS AMONG VARIOUS 
HEREDITARY MUSCLE DISORDERS 
DISTRIBUTION OF 
WEAKNESS DIAGNOS IS OF 
MUSCLE DISORDERS PROXIMAL DISTAL BOTH 
Total 
DMD (n = 2) 1 0 1 2 
BMD (n = 5) 4 0 1 5 
FSHD (n = 5) 3 0 2 5 
LGMD (n = 25) 12 0 13 25 
MYOTONIC 
DYSTROPHY (n = 3) 1 1 1 3 
DISTAL MYOPATHY 
(n = 2) 0 2 2 2 
CONGENITAL 
MYOPATHY (n = 2) 2 0 0 2 
Total 23 3 18 44 
p<0.001 
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Among 25 patients with LGMD, 12(48%) had proximal weakness 
and 13(52%) had both proximal and distal weakness. Among 5 with 
BMD, 4(80%) had proximal and 1(20%) had proximal and distal 
weakness. Among 5 with FSHD, 3(60%) had proximal weakness and 
2(40%) had both proximal and distal weakness. Out of 3 with Myotonic 
dystrophy, 1(33.3%) had proximal weakness, 1(33.3%) had distal 
weakness and 1(33.3%) had both. Among 2 with DMD, 1(50%) had 
proximal weakness and 1(50%) had both. All 2(100%) patients with 
distal myopathy had distal weakness. 2(100%) patients with Congenital 
myopathy had proximal weakness.   It was found that the distribution of 
weakness among various hereditary muscle disorders and the part of the 
body affected was found to be statistically signif icant (p<0.001). 
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Table - 11 
DISTRIBUTION OF THE LIMB INVOLVEMENT AMONG 
VARIOUS HEREDITARY MUSCLE DISORDERS 
LIMBS DIAGNOS IS OF 
MUSCLE DISORDERS UPPER 
LIMB 
LOWER 
LIMB BOTH 
Total 
DMD (n = 2) 0 0 2 2 
BMD (n = 5) 0 0 5 5 
FSHD (n = 5) 3 0 2 5 
LGMD (n = 25) 0 4 21 25 
MYOTONIC 
DYSTROPHY (n = 3) 0 0 3 3 
DISTAL MYOPATHY 
(n = 2) 0 2 0 2 
CONGENITAL 
MYOPATHY (n = 2) 0 0 2 2 
Total 3 6 35 44 
p<0.001 
Among 25 patients with LGMD, 21(84%) had both upper and 
lower limb involved and 4(16%) had only lower limb involved. Out of 5 
with FSHD, 3(60%) had only upper limb involvement and 2(40%) had 
both upper and lower limb involved.  All 5(100%) with BMD had both 
upper and lower limb involvement.  All 3(100%) with Myotonic 
dystrophy had both upper and lower limb involvement. All 2 (100%) 
patients with DMD had both upper and lower limb involvement.  All 
2(100%) with Distal myopathy had only involvement of lower limbs.  All 
2(100%) with Congenital myopathy had both upper and lower limb 
involved.  The distribution of limb involvement among various hereditary 
muscle disorders was found to be statistically signif icant (p<0.001). 
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Figure – 2  
Scapular winging in one of our patient with FSHD  
(Angel wing appearance)  
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Table - 12 
PATTERN OF INVOLVEMENT IN HEREDITARY MUSCLE 
DISORDERS 
PATTERN OF INVOLVEMENT 
CLINICAL 
DIAGNOS IS Pattern  
1 
Pattern 
2 
Pattern 
3 
Pattern 
4 
Pattern 
5 
Pattern 
6 
 
Total 
DMD 2(100% ) 0 0 0 0 0 2 
BMD 5(100% ) 0 0 0 0 0 5 
FSHD 4(80%) 0 1(20%) 0 0 0 5 
LGMD 25(100%) 0 0 0 0 0 25 
Myotonic- 
dystrophy 2(66.7%) 1(33.3%) 0 0 0 0 3 
Congenital- 
myopathy 2(100% ) 0 0 0 0 0 2 
Distal-
myopathy 0 2(100% ) 0 0 0 0 
2 
 
Total 40 3 1 0 0 0 44 
 Pattern-1 - proximal limb-girdle, Pattern-2 - distal weakness, Pattern-3 - 
proximal arm/distal leg weakness, Pattern-4 - distal arm/proximal leg weakness, 
Pattern-5 -ptosis with or without ophthalmoplegia, pattern-6 - prominent neck 
extensor weakness. 
 Proximal limb-girdle pattern (90.9%) was the most common 
pattern of weakness in our study,which was found in all(100%) of 
patients with DMD,BMD,LGMD,Congenital myopathy and  in 4(80 %) 
of patients with FSHD.It was also seen in 2(66.7%) of patients with 
myotonic dystrophy.The next common pattern was distal pattern (6.8%) 
which was found in all 2(100%) of patients with distal myopathy and in 
1(33.3%) patient with myotonic myopathy.The third pattern, proximal 
arm/distal leg pattern (2.3%)was found in 1(20%) of patients with FSHD. 
No other pattern of weakness was found in our study. 
 58 
Table - 13 
SPECIFIC CLINICAL SIGNS 
Clinical signs DMD BMD LGMD FSHD Myotonic dystrophy 
Congenital 
myopathy 
Distal 
myopathy 
Calf 
Hypertrophy 
2 
(100%) 
4 
(80%) 
5 
(20%) 0 0 0 0 
Gowers sign 2 (100%) 
2 
(40%) 
7 
(28%) 0 0 0 0 
Scapular 
winging 0 0 
5 
(20%) 
5 
(100%) 0 0 0 
Polyhill sign 0 0 0 5 (100%) 0 0 0 
Calf atrophy 0 0 3 (12%) 0 0 0 
1 
(50%) 
Diamond 
quadriceps 0 0 
4 
(16%) 0 0 0 0 
Hip 
abduction 
sign 
0 0 8 (32%) 0 0 0 0 
Biceps lump 0 0 4 (16%) 0 0 0 0 
Valley sign 1 (50%) 
1 
(20%) 
1 
(4%) 0 0 0 0 
Contractures 1 (50%) 
1 
(20%) 
4 
(16%) 0 0 0 0 
Hatchet 
facies 0 0 0 0 
2 
(66.7%) 0 0 
Myotonia 0 0 0 0 3 (100%) 0 0 
 Specific clinical findings found among various hereditary muscle 
disorders in our study are shown in the table 11.All 5(100%) 0f patients 
with FSHD had polyhill sign and scapular winging.All 2(100%) of 
patients with DMD had gower’s sign and calf hypertrophy.All 3(100%) 
patients with myotonic dystrophy had percussion or grip myotonia.Biceps 
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hump(16%),Diamond quadriceps(16%),Hip abduction sign(32%),calf 
atrophy(12%) were the specific signs noted in our LGMD patients. 
Table – 14  
DISTRIBUTION OF SUBJECTS WITH DIAGNOSIS OF 
HEREDITARY MUSCLE DISORDERS AND SERUM CREATINE 
KINASE VALUE 
VALUE OF S ERUM CREATINE KINAS E 
 
DIAGNOS IS OF 
MUSCLE 
DISORDERS 
<250 
251 
–  
1000 
1001 
–  
2000 
2001 
–  
3000 
3001 
-  
4000 
5001 
-  
6000 
8001 
-  
9000 
Total 
DMD (n = 2) 0 0 1 0 0 1 0 2 
BMD (n = 5) 0 0 1 1 1 2 0 5 
FSHD (n = 5) 2 3 0 0 0 0 0 5 
LGMD (n = 25) 0 12 9 0 3 0 1 25 
MYOTONIC 
DYSTROPHY (n = 
3) 
0 1 2 0 0 0 0 3 
DISTAL 
MYOPATHY 
(n = 2) 
0 2 0 0 0 0 0 2 
CONGENITAL 
MYOPATHY  
(n = 2) 
0 2 0 0 0 0 0 2 
Total 2 20 13 1 4 3 1 44 
p<0.031 
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 Among 25 patients with LGMD 12(48%) had serum creatinine 
kinase(CK) level between 251-1000,9(36%) between 1001-2000 and 
3(12%) have between 3001 – 4000.Out of 5 with BMD 2(40%) had CPK 
between 5001 – 6000,1(20%) had between 1001-2000 and 1(20%) 
between 2001-3000 and 1(20%) had between 3001-4000. Among 5 with 
FSHD  2(40%) have CK level < 250 and 3(60%) have between 251 to 
1000. Out of 3 with Myotonic dystrophy, 2(66.67%) have CK level 
between1001- 2000 and 1(33.33%) had between 251-1000. All 2(100%) 
with distal myopathy have CK level between 251-1000. All 2 (100%)with 
Congenital myopathy had CK level between 251-1000. Out of 2 with 
DMD, 1(50%) had CK level between 1001-2000 and 1(50%) had between 
5001-6000.The differences in the CPK level among patients with muscle 
disorders was found to be statistically significant(p< 0.031). 
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Table  - 15 
DISTRIBUTION OF SUBJECTS WITH DIAGNOSIS OF 
HEREDITARY MUSCLE DISORDERS AND ECG AND ECHO 
ECG / ECHO DIAGNOS IS OF 
MUSCLE 
DISORDERS Normal Abnormal 
Total 
DMD (n = 2) 0 2 2 
BMD (n = 5) 4 1 5 
FSHD (n = 5) 4 1 5 
LGMD (n = 25) 24 1 25 
MYOTONIC 
DYSTROPHY (n = 3) 3 0 3 
DISTAL 
MYOPATHY 
(n = 2) 
2 0 2 
CONGENITAL 
MYOPATHY (n = 2) 1 1 2 
Total 38 6 44 
p<0.006 
 
 Out of 25 patients with LGMD, 24(96%) had normal cardiac status, 
while 1(4%) had abnormal cardiac status. Among 5 with FSHD, 4(80%) 
had normal cardiac status and 1(20%) had abnormality. Among 5 with 
BMD, 4(80%) had normal cardiac status and (20%) had abnormality. All 
3(100%) with Myotonic dystrophy had normal cardiac status.All 2(100%) 
with DMD had normal cardiac status. All 2(100%) with Distal myopathy 
had normal status. Among 2 with Congenital myopathy,1(50%) had 
normal and 1(50%) had abnormal cardiac status.The difference was found 
to be statistically significant(p<0.006). 
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Table – 16  
DISTRIBUTION OF SUBJECTS WITH DIAGNOSIS OF MUSCLE 
DISORDERS AND EMG 
EMG DIAGNOS IS OF 
MUSCLE 
DISORDERS MYOPATHIC MYOTONIC 
Total 
DMD (n = 2) 2 0 2 
BMD (n = 5) 5 0 5 
FSHD (n = 5) 5 0 5 
LGMD (n = 25) 25 0 25 
MYOTOINIC 
DYSTROPHY (n = 3) 0 3 3 
DISTAL 
MYOPATHY 
(n = 2) 
2 0 2 
CONGENITAL 
MYOPATHY (n = 2) 2 0 2 
Total 41 3 44 
p<0.001 
   
 All 25(100%) with LGMD had myopathic EMG pattern. All 
5(100%) with FSHD had myopathic pattern. All 5(100%) with BMD had 
myopathic pattern. All 3 (100%)with Myotonic dystrophy had myotonic 
picture. All 2 (100%)with DMD had myopathic picture in EMG. All 
2(100%) with Distal myopathy had myopathic picture. All 2(100%) with 
Congenital myopathy had myopathic picture.The differences was found 
to be statistically significant(p<0.001). 
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Table – 17  
DISTRIBUTION OF SUBJECTS WITH DIAGNOSIS OF MUSCLE 
DISORDERS AND MUSCLE BIOPSY 
MUSCLE BIOPSY DIAGNOS IS OF 
MUSCLE 
DISORDERS MD NO DYSTROPHY 
Total 
DMD (n = 2) 2 0 2 
BMD (n = 5) 5 0 5 
FSHD (n = 5) 5 0 5 
LGMD (n = 25) 25 0 25 
MYOTONIC 
DYSTROPHY (n = 3) 2 1 3 
DISTAL 
MYOPATHY 
(n = 2) 
2 0 2 
CONGENITAL 
MYOPATHY (n = 2) 1 1 2 
Total 42 2 44 
p<0.009 
MD-Muscular dystrophy 
All 25(100%) patients with LGMD showed muscle dystrophy in 
muscle biopsy. All 5(100%) with FSHD showed muscle dystrophy. All 
5(100%) with BMD showed muscle dystrophy. Out of 3 with Myotonic 
dystrophy, 2(66.67%) showed muscle dystrophy and 1(33.33%) showed 
no muscle dystrophy. Out of 2 with congenital myopathy, 1(50%) showed 
muscle dystrophy and the other(50%)had specific feature(Nemaline rods) 
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but without dystrophy. All 2(100%) with DMD showed muscle 
dystrophic pattern. All the 2 (100%)with distal myopathy showed muscle 
dystrophy and the differences was  statistically significant(p<0.009). 
Table 18 
CORRELATION BETWEEN THE CLINICAL DIAGNOSIS OF 
HEREDITARY MUSCLE DISORDERS AND ELEVATED SERUM 
CREATINE KINASE VALUE 
  
ELEVATED 
SERUM 
CREATINE 
KINAS E 
VALUE 
CLINICAL 
DIAGNOS IS 
Pearson 
Correlation 1   .413
**
 
Sig. (2-tailed)  .005 
ELEVATED 
SERUM 
CREATINE 
KINAS EVALUE 
N 44 44 
Pearson 
Correlation   .413
**
 1 
Sig. (2-tailed) .005  
CLINICAL 
DIAGNOS IS 
N 44 44 
**. Correlation is significant at the 0.01 level (2-tailed).  
 
 A high degree of correlation was found between the clinical 
diagnosis of hereditary muscle disorders and elevated serum creatine 
kinase which was statistically significant with a p value of <0.005. 
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Table 19 
CORRELATION BETWEEN THE CLINICAL DIAGNOSIS OF 
HEREDITARY MUSCLE DISORDERS AND MYOPATHIC EMG 
   
MYOPATHIC 
EMG 
CLINICAL 
DIAGNOS IS 
Correlation 
Coefficient 1.000 .487
**
 
Sig. (2-tailed) . .001 
MYOPATHIC 
EMG 
N 44 44 
Correlation 
Coefficient .487
**
 1.000 
Sig. (2-tailed) .001 . 
Spearman's 
rho 
CLINICAL 
DIAGNOS IS 
N 44 44 
**. Correlation is significant at the 0.01 level (2-tailed).  
 
A high degree of correlation was found between the clinical diagnosis of 
hereditary muscle disorders and myopathic EMG which was statistically 
signif icant with a p value of <0.001. 
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Table 20 
CORRELATION BETWEEN THE CLINICAL DIAGNOSIS OF 
HEREDITARY MUSCLE DISORDERS AND MYOPATHIC 
PATTERN OF MUSCLE BIOPSY  
   
MYOPATHIC 
PATTERN OF 
MUSCLE 
BIOPSY 
CLINICAL 
DIAGNOS IS 
Correlation 
Coefficient 1.000 .357
*
 
Sig. (2-tailed) . .017 
MYOPATHIC 
PATTERN OF 
MUSCLE 
BIOPSY 
N 44 44 
Correlation 
Coefficient .357
*
 1.000 
Sig. (2-tailed) .017 . 
Spearman's 
rho 
CLINICAL 
DIAGNOS IS 
N 44 44 
*. Correlation is significant at the 0.05 level (2-tailed).   
 A high degree of correlation was found between the clinical 
diagnosis of hereditary muscle disorders and myopathic pattern in muscle 
biopsy which was statistically signif icant with a p value of <0.005. 
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DISCUSSION 
 Hereditary muscle disorders are more common than acquired 
myopathies.clinical suspicion,correct approach and appropriate 
investigations will lead us to an accurate diagnosis.Demographic and 
clinical spectrum of hereditary muscle disorders with its correlation to 
laboratory parameters are discussed in the following section. 
 In our study with a total of 44 patients ,32(72.7%) were males and 
12(26.3%) were females.In LGMD out of 25 patients,16(64%) were 
males and 9(36%) were females,whereas in a study by Meena et al18 it 
was 54%  and 46% for males and females respectively. All 2(100%)  
patients with congenital myopathy were females. 
 In a total of 44 patients with hereditary muscle disorders,40(91%) 
were muscular dystrophies.LGMD is the most common hereditary muscle 
disorders in our study(57%) and DMD is found in only 5%,which is in 
contrast to a study by Das et al19 where both DMD(30%) and 
LGMD(29.2%) were equally prevalent.This gross difference in 
prevalence in our study could be due to the fact that most of the DMD 
patients possibly were evaluated and treated by paediatric neurologist  
whereas our centre is an adult referral hospital and so only ,less number 
of patients were referred here for neurological consultation.According to 
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another Indian study(Khadhilkar S V et al) LGMD formed the most 
common hereditary muscle disorder, which is consistent with our study.20 
 The age distribution in our patients showed that 20% of the patients 
were in the age group of less than 15 years which is in line with  a study 
by  Buchthal F et al,21 in which 25% of the myopathic patients were in 
that age group.Majority of our patients were young(2nd decade).No 
patients with hereditary muscle disorders are found beyond 5th decade in 
our study.Earliest age at onset in our study was 2 years(DMD) and late 
age at onset was 50 years(FSHD).All 2(100%) patients with congenital 
myopathy had age at onset in 3rd decade.This shows that our patients with 
congenital myopathy could be the milder adult onset variants.22All 2 
(100%) patients with distal myopathy had early age onset (2nd 
decade),one of the patient had autosomal dominant mode of 
inheritance(Laing syndrome).The other patient had no clear family 
history,without neck weakness and the  biopsy showed fibre necrosis 
without rimmed vacuoles and so she could be a case of miyoshi 
myopathy.This shows that the distal myopathy(Laing or Miyoshi) are not 
uncommon  in our population.  
 Among all patients with muscular dystrophies(40), only 3(7.5%) 
were myotonic dystrophy which correlates with another Indian study(8%) 
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by Gourie devi et al.23FSHD constitutes 12.5% of patients with muscular 
dystrophies,which is in contrast to other Indian studies where only 2.3% 
and 1.3% were seen by Srinivas et al.24 and Das et al 
respectively.congenital myopathy and distal myopathy were diagnosed in 
2(4.5%) patients each, equal to the incidence of DMD(4.5%) which is 
consistent with the incidence from  a study by Nonaka I et al.25 
 Among 44 patients only 4(9.1%) patients had asymmetric 
weakness.As comparable to many previous studies, asymmetric weakness 
was more common in FSHD patients(6.8%).In our study , asymmetric 
muscle weakness was also noted in a patient with LGMD(2.3%) which 
was also observed in previous study by Khadilkar S V et al(42%).26 
 Most of our patients with positive family history had autosomal 
recessive mode of inheritance and this could be due to the commonly 
practiced custom of consanguineous marriage in our population.Next 
common mode of inheritance was X-linked recessive followed by 
autosomal dominant pattern.Among LGMD 28% of patients had AR 
pattern and  no patients had AD pattern of inheritance,which correlates 
well with a previous Indian study by Khadhilkar et al. 
 Weakness involving both upper and lower limbs were commonly 
seen in our patients(79.5%) which is consistent with many previous 
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studies.27This could possibly due to the fact that most of our patients seek 
medical advice only late in the illness.Only upper limb weakness without 
involving lower limbs were noted in 3(60%) patients with FSHD which is 
parallel to a study by Pradhan et al.28Weakness of only lower limbs 
without upper limb weakness were observed in all 2(100%)patients with 
distal myopathy and in 16% of patients with LGMD. 
 Pattern of involvement is important in the clinical diagnos is of 
hereditary muscle disorders,because each of these disorders have a 
distinct pattern in most of the occasions.Most of our patients(88.6%) had 
proximal limb-girdle pattern of muscle weakness and patients with 
hereditary muscle disorders like DMD 
(100%),BMD(100%),LGMD(100%),congenital myopathy (100%) were 
fitting well in this group. This is consistent with many previous studies 
(Barohn RJ et al)4.Next common pattern seen was the distal pattern, 
with both the patients of distal myopathy  (100%) and myotonic 
dystrophy(33.3%) were observed. The third pattern with proximal 
arm/distal leg weakness was seen in only one patient(FSHD). 
 Many specific clinical signs were described that helps to diagnose 
hereditary muscle disorders with certainty.Calf hypertrophy was observed 
in DMD(100%),BMD(80%) and in some of the LGMD patients(20%).In 
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contrast to our study,53.8% of patients with LGMD(Sarcoglycanopathies) 
had calf hypertrophy in a study by Meena et al,.29Gowers sign was seen in 
DMD(100%),BMD(40%) and in 28% of patients with LGMD.This sign 
along with calf hypertrophy in young boys are diagnostic of 
DMD(Mansur et al)30.Contractures in patients with muscular dystrophy 
is well described in literature which was also noted in our 
patients.Contractures were seen in DMD(50%),BMD(20%) and in 
LGMD(16%) which correlates with a study  by Mansur et al. 
 All 5(100%) patients with FSHD had polyhill s ign which is due to 
a differential wasting in certain muscles with relative preservation of 
muscle bulk around shoulder  girdle.This is specifically seen in patients 
with FSHD(Pradhan et al).28Winging of scapula(Angel wing appearance) 
was also seen in all 5(100%) of patients with FSHD, but this was also 
noted in some LGMD patients.Atrophy of calf muscles(12%),Biceps 
lump(due to differential wasting in biceps)16% and Diamond 
quadriceps(16%) were also noted in our patients with LGMD,which has 
been described in patients with LGMD(dysferlinopathy) by Pradhan et 
al,.31,32 
 Hip abductor sign with splaying of legs while getting up from 
squatting ,which occurs due the profound weakness of hip adductors with 
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preserved hip abductors is well documented to occur in patients with 
LGMD like sarcoglycanopathy(Khadhilkar et al).33This sign was seen in 
8(32%) patients with LGMD in our study.Hip abductor sign is helpful in 
differentiating LGMD from DMD/BMD,since in the later hip 
abductors,quadriceps and iliopsoas are involved earlier with severe 
degree of weakness as compared to hip adductor/hamstrings involvement 
in LGMD.The specific signs that are described in literature were also 
noted in our study,but only in a lesser number of patients. 
 Valley sign(due to the prominent wasting in posterior axillary 
muscles with relatively preserved deltoid and infraspinatus) described by 
Pradhan et al,was observed in 1(50%)patient with DMD,1 with 
BMD(20%) and1with LGMD(4%) in our study.34 
 CK elevation was found in all patients in our study, but the degree 
of elevation differs among various hereditary muscle disorders(Wong E T 
et al).5It was maximal(>25 times normal)in patients with 
DMD(50%),BMD(40%) and in LGMD(4%).All these patients had 
similar phenotype with severe degree of weakness.Mild to moderate 
elevations(2-25 times normal) was found in most of our patients with 
LGMD,congenital myopathy and distal myopathy.Minimal elevation was 
found in FSHD patients as described in literature.35 
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 In a previous study by Mansur et al,72% of  BMD patients had 
cardiac involvement which was not found in our study where only 20% 
had abnormal ECG/ECHO findings.Whereas all 2(100%) DMD 
patients,1(20%) FSHD,1(4%) of LGMD and1(50%) of congenital 
myopathy had cardiac involvement. 
 High degree of correlation between clinical diagnosis of hereditary 
muscle disorders and myopathic EMG was found.Myopathic pattern was 
observed in all patients of Muscular dystrophy,congenital myopathy and 
distal myopathy.All 3(100%) myotonic dystrophy patients showed 
spontaneous activity(myotonic discharges) in EMG study.This is 
consistent with other previous studies(Garima Shukla et al ,Black JT et 
al. ,Peter K et al. ,Buchthal et al.).36,37,38,19 
 Muscle biopsy study in our patients showed that,all patients with 
muscular dystrophy(100%),1(50%) patient with congenital myopathy and 
in 2(66.7%) patients with myotonic dystrophy had myopathic 
pattern.1(50%) patient with congenital myopathy had specific changes of 
internal structure in muscle fibres(Nemaline rods).39Clinical diagnos is of 
hereditary muscle disorders and concordant myopathic pattern in muscle 
biopsy study was found in more than 90% of our patients as comparable 
to many previous studies(Buchthal et al. ,Peter K et al..Schwartz et al, 
).19,38,40 
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CONCLUSION 
  In conclusion, the following observations were made from our 
study,  
• Hereditary muscle disorders are common among males than in 
females. 
• Most of the patients with hereditary muscle disorders were in the 
age group of 10 to 20 years(2nd decade). 
• Earliest age of onset in our study was 2 years (DMD). 
• No patients with hereditary muscle disorders were found beyond 
5th decade in our study. 
• Most common hereditary muscle disorders was LGMD(57%) 
followed by FSHD(11.4%) and BMD(11.4%).  
• Most common pattern of involvement was proximal limb girdle 
pattern with all DMD,BMD,LGMD,Congenital myopathy patients 
in that group. 
• Polyhill s ign and scapular winging were seen in all our patients 
with FSHD,which is a characteristic finding in this disease. 
Specific clinical signs were less commonly noted in our patients 
with LGMD.  
• Serum CK elevation is maximum (>25 times normal) in 
DMD,BMD,LGMD(AR inheritance) and  minimum(1-2 times 
normal) in FSHD and the CK elevation correlates well with the 
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clinical phenotype among various hereditary muscle disorders in 
our population.A strong correlation between elevated serum CK 
and clinical diagnosis of hereditary muscle disorders was noted in 
our study. 
• High degree of concordance of clinical diagnosis of hereditary 
muscle disorders with EMG was observed in our study. 
• High degree of concordance of clinical diagnosis of hereditary 
muscle disorders with muscle biopsy was observed in our study. 
 Hence, a structured clinical approach focusing on pattern of muscle 
involvement and on specific clinical signs along with investigations 
like serum CPK,EMG and Muscle biopsy,it is possible to make an 
accurate early diagnos is in hereditary muscle disorders,prognosticate 
and manage them appropriately to improve the quality of life in these 
patients. 
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 ABBREVIATIONS 
 

BMD   : Becker’s muscular dystrophy 
CK   : Creatine Kinase 
DMD   : Duchene muscular dystrophy 
EMG   : Electromyography 
FSHD  : Facioscapulohumeral muscular dystrophy 
LGMD  : Limb Girdle muscular dystrophy 
MD                        : Muscular dystrophy 
MUAP  : Motor unit action potenial  
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19 X-linked recessive Y Y N N Y N  -- + - - - - - 
20 Autosomal Recessive N Y N N N N  -- + - - - - - 
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21 Autosomal Dominant N N N N N N N -- + - - - P - 
22 Not clear Y Y N N N N N -- + - - - - - 
23 X-linked recessive Y Y N N N N  -- + - - - - - 
24 No history N Y N Y N N  -- + - - - - - 
25 Autosomal Dominant Y N N N N N N -- - - - - - - 
26 Not clear N Y N Y N N  -- + - - - - - 
27 Not clear N Y N N N N  -- + - - - - - 
28 Autosomal Recessive N N N N N N N -- + - - - - - 
29 No history N Y N N N N N -- + - - - - - 
30 Autosomal Recessive Y N N N N N N -- + - - - - - 
31 No history Y N N N N N  -- + - - - - - 
32 Not clear N N N N Y N N Toe Walking + - - - - - 
33 Not clear N N N N N N N -- + - - - - - 
34 Not clear N N N N N N N -- + - - - - - 
35 No history N Y N Y N N  -- + - - - - - 
36 Not clear N Y N N   N N Toe Walking + - - - - - 
37 No history Y N N N N N N -- + - - - - - 
38 No history N N N N N N N -- + - - - - - 
39 Autosomal Recessive N Y N Y N N  -- + - - - - - 
40 X-linked recessive Y N N N N N  -- + - - - - - 
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41 X-linked recessive Y N N N N N N -- + - - - - - 
42 Not clear N Y N N N N  -- + - - - - - 
43 Not clear N Y N N N N N -- + - - - - - 
44 Not clear N Y N N N N N -- -  - - - - 
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1 WG AbN Nil 3209 RBBB - N Myopathic M.D. LGMD 
2 N AbN Nil 105 N - N Myopathic M.D. FSHD 
3 WG   Nil 600 N - N Myopathic M.D. LGMD 
4 WG AbN Nil 1042 N - N Myopathic M.D. LGMD 
5 WG AbN Nil 3294 N - N Myopathic M.D. LGMD with 
rimmed vacuoles 
6 WG   Nil 745 N - N Myopathic M.D. LGMD 
7 WG Gower's 
sign 
Nil 5639 N - N Myopathic M.D. ?BMD 
8 N Hand  grip Nil 1261 N - N 
Spont 
activity M.D. 
?Myotonic 
dystrophy 
Type I 
9 N - Nil 986 N - N Myopathic M.D. Distal Myopathy 
10 WG - Nil 1106 N - N Myopathic M.D. LGMD 
11 WG - Nil 904 N - N Myopathic M.D. LGMD 
12 WG - Nil 1320 N - N Myopathic M.D. LGMD 
13 WG Gower's 
sign Nil 3347 
RBBB 
Mild TR 
with RVH 
- N Myopathic M.D. BMD 
14 WG Gower's 
sign Nil 5885 N N N Myopathic M.D. DMD 
15 - AbN Nil 1080 N N N Myotonic  discharge - 
Myotonic 
dystrophy 
16 
Toe 
walking 
wadding 
AbN Nil 1877 N N N Myopathic M.D. LGMD 
   INVESTIGATIONS 
S
l
.
N
o
.
 
GAIT 
O
T
H
E
R
 
F
I
N
D
I
N
G
S
 
U
R
I
N
E
 
M
Y
O
G
L
O
B
I
N
U
R
I
A
 
S
E
R
U
M
 
C
R
E
A
T
I
N
E
 
K
I
N
A
S
E
 
E
C
G
 
/
 
E
C
H
O
 
O
P
P
H
T
H
A
L
M
O
L
O
G
Y
 
N
E
R
V
E
 
C
O
N
D
U
C
T
I
O
N
 
S
T
U
D
Y
 
E
L
E
C
T
R
O
 
M
Y
O
G
R
A
P
H
Y
 
M
U
S
C
L
E
 
B
I
O
P
S
Y
 
P
r
o
v
i
s
i
o
n
a
l
 
D
i
a
g
n
o
s
i
s
 
17 WG - Nil 340 N N N Myopathic M.D. LGMD 
18 N AbN Nil 357 N N N Myopathic M.D. FSHD 
19 WG Gower's 
sign Nil 1800 AbN - N Myopathic M.D. DMD 
20 N - Nil 1330 N - N Myopathic M.D. LGMD 
21 N AbN Nil 590 N N N Myotonic  discharge M.D. 
Congenital 
myopathy 
22 N - Nil 1135 N N N Myopathic M.D. LGMD 
23 WG - Nil 5239 N - N Myopathic M.D. BMD 
24 WG AbN Nil 407 N - N Myopathic M.D. FSHD 
25 N AbN Nil 625 N - N Myotonic  discharge - 
Myotonic 
dystrophy 
26 WG AbN Nil 562 N - N Myopathic M.D. FSHD 
27 WG Gower's 
sign Nil 1345 N - N Myopathic M.D. LGMD 
28 WG - Nil 3410 N N N Myopathic M.D. LGMD 
29 WG - Nil 590 N N N Myopathic M.D. LGMD 
30 WG AbN Nil 1120 N - N Myopathic M.D. LGMD 
31 -- - Nil 960 N - N Myopathic M.D. LGMD 
32 WG - Nil 8155 N N N Myopathic M.D. LGMD 
33 - AbN Nil 167 N N N Myopathic M.D. FSHD 
34 WG AbN Nil 434 N N N Myopathic M.D. LGMD 
35 WG AbN Nil 305 N - N Myopathic M.D. LGMD 
36 WG - Nil 1201 N - N Myopathic M.D. LGMD 
37 WG - Nil 510 N - N Myopathic M.D. LGMD 
38 WG - Nil 996 N - N Myopathic M.D. LGMD 
39 WG AbN Nil 356 AbN - N Myopathic M.D. Congenital 
myopathy 
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40 WG AbN Nil 2100 N - N Myopathic M.D. BMD 
41 WG AbN Nil 1900 N - N myopathic M.D. BMD 
42 WG - Nil 953 N N N mayopathic M.D. LGMD 
43 WG - Nil 590 N N N myopathic M.D. LGMD 
44 High  
steppage foot drop Nil 498 N - N myopathic M.D. Distal Myopathy 
 
PROFORMA 
 
Name:    Age:  Sex:  OP / IP No.: 
 
Address:       
 
Mobile / Tel.No.: 
 
History: 
 
 Age at onset    : 
 Mode of onset   : 
 Duration of illness   : 
 Progression    :  Static / Progressive / Improving 
 H/o. Fatiguability   :  Present / Absent 
 H/o. Diurnal Variation  :  Present / Absent 
 H/o. Constitutional symptoms :  Present / Absent 
 H/o. Muscle pain   :  Present / Absent 
 H/o. Chronic drug usage / Exposure to toxins 
 
Weakness: 
 
 Symmetrical / Asymmetrical 
 Proximal / Distal / Both 
 Limbs     :  UL / LL / Both 
 Trunk     :  Present / Absent  
 Neck Muscles    :  Present / Absent  
 Facial Muscles    :  Present / Absent  
 H/o. Breathlessness(Respiratory Mm) :  Present / Absent  
H/o. Thinning of muscles    :  Present / Absent  
Exertion     :  Worsens / Improves 
Cold / Warmth    :  Worsens / Improves  
Past History: 
 
 Similar illness / DM / S HT / HD / BA / P.TB / SZ / Surgery 
Personal History: 
 
 Smoking   : Present / Absent 
 Alcohol    : Present / Absent 
 Substance abuse  : Present / Absent 
 Diet    : Veg. / Non.Veg / Mixed 
 
Family History: 
 
On Examination: 
 
1. Muscle Hypertrophy : Present / Absent 
2. Muscle Wasting : Present / Absent 
3. Muscle Fasciculation : Present / Absent 
4. Skeletal deformities : Present / Absent 
5. Contractures  : Present / Absent 
6. Muscle Tenderness : Present / Absent 
7. Tone   : Normal / Hypotonia / Hypertonia 
8. Toe / Heel Walking : Present / Absent  
Power: 
Upper Limb  Right Left 
Shoulder 
ABD 
ADD 
FLEX 
EXT 
IR 
ER 
  
Elbow FLEX EXT   
Wrist FLEX EXT   
Hand grip    
 
 Lower Limb  Right Left 
Hip 
ABD 
ADD 
FLEX 
EXT 
IR 
ER 
  
Knee FLEX EXT   
Ankle Dorsiflexion Plantarflexion   
Toe Grip    
Neck Mm FLEX EXT   
 
Pattern of Muscle involvement: 
1. Proximal limb-girdle weakness  : Present / Absent 
2. Distal weakness     : Present / Absent 
3. Proximal arm / distal leg weakness  : Present / Absent 
4. Distal arm / proximal leg weakness  : Present / Absent 
5. Ptosis with /without ophthalmoplegia  : Present / Absent 
6. Prominent neck extensor weakness  : Present / Absent 
Deep Tendon Reflexes : BJ SJ TJ KJ AJ 
   Right  : 
   Left : 
GAIT    : 
Other Findings  : 
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